Patents by Inventor Dominik Jordan

Dominik Jordan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9260680
    Abstract: A process for the preparation of a beverage, a beverage base, a beverage concentrate or a beverage additive having a reduced prolamin content from prolamin-containing raw materials, comprising the following steps: a) contacting the beverage or a precursor of the beverage with cross-linking enzymes to obtain modified prolamin; b) removing the modified prolamin at least partially.
    Type: Grant
    Filed: November 10, 2005
    Date of Patent: February 16, 2016
    Assignee: N-Zyme Biotech GmbH
    Inventors: Ralf Pasternack, Stefan Marx, Dominik Jordan
  • Publication number: 20080003327
    Abstract: A process for the preparation of a beverage, a beverage base, a beverage concentrate or a beverage additive having a reduced prolamin content from prolamin-containing raw materials, comprising the following steps: a) contacting the beverage or a precursor of the beverage with cross-linking enzymes to obtain modified prolamin; b) removing the modified prolamin at least partially.
    Type: Application
    Filed: November 10, 2005
    Publication date: January 3, 2008
    Inventors: Ralf Pasternack, Stefan Marx, Dominik Jordan
  • Publication number: 20060172300
    Abstract: The invention relates to a method for identifying the presence of BBB-specific protein/fragment in endothelial cells of brain capillaries, characterized in that a) endothelial cells of brain capillaries freshly isolated from brain are conventionally pre-purified by enzymatic digestion, b) the digest obtained in step a) is treated with a lysis buffer that essentially destroys present erythrocytes and apoptotic cells and maintains at least 70% of the endothelial cells of brain capillaries in vital form, c) the product obtained in step b) is optionally purified further, d) a subtractive cDNA library is prepared from the endothelial cells of brain capillaries and a subtractive tissue, e) a cDNA subtraction is performed using one ore more differential hybridization(s), f) clones from the subtractive cDNA library are verified by differential hybridization with respect to their respective expression, g) a complete cDNA sequence is prepared for the BBB-specific clones from the subtractive cDNA library, and h) the exp
    Type: Application
    Filed: March 8, 2003
    Publication date: August 3, 2006
    Applicant: FrankGen Biotechnologie AG
    Inventors: Sabine Wolf, Martina Jager, Thorsten Bangsow, Carmen Bangsow, Dominik Jordan, Bernhard Pelzer, Thomas Oppolzer